Cardiac Resynchronisation Therapy is Cost Effective

Conflicts of interests: Drs Freemantle and Cleland were members of the CARE-HF trial Steering Committee funded by Medtronic. All authors received funding to attend meetings and undertake work relating to the trial and authored the cost-effectiveness analyses. All authors have received honoraria for speaking at meetings and research funding from companies in the pharmaceutical and device industries.